Baudette-based ANI Pharmaceuticals says its entered into an agreement with another company to produce and market a generic drug product.
ANI says the unnamed product will be developed by Illinois-based Sterling Pharmaceutical Services, later manufactured and marketed out of it's Baudette facility.
The company says the estimated value of the market for the drug is about 60-million dollars.